Vertaling van "drugs don't work " (Frans → Nederlands) :

2011: Ben Hirschler et Kate Kelland (Royaume-Uni), pour leur article sur la résistance antimicrobienne, « When the drugs don't work », publié par Reuters.
2011: Ben Hirschler en Kate Kelland (Verenigd Koninkrijk) met een artikel over antibioticaresistentie " When the drugs dont't work " , gepubliceerd door Reuters.

2011: Ben Hirschler et Kate Kelland (Royaume-Uni), pour leur article « When the drugs don't work » sur la résistance antimicrobienne, publié par Reuters.
2011: Ben Hirschler en Kate Kelland (Verenigd Koninkrijk) met een artikel over antibioticaresistentie " When the drugs don't work " , gepubliceerd door Reuters.

2011: Ben Hirschler et Kate Kelland (Royaume-Uni), pour leur article « When the drugs don't work » sur la résistance antimicrobienne, publié par Reuters.
2011: Ben Hirschler en Kate Kelland (Verenigd Koninkrijk) met een artikel over antibioticaresistentie " When the drugs dont't work " , gepubliceerd door Reuters.

Les lauréats de l'édition 2011 sont Ben Hirschler et Kate Kelland du Royaume-Uni, pour leur article « When the drugs don't work » sur la résistance antimicrobienne, publié par Reuters.
De winnaars van 2011 zijn Ben Hirschler en Kate Kelland uit het Verenigd Koninkrijk met een artikel over antibioticaresistentie " When the drugs dont't work " , gepubliceerd door Reuters.

Horizontal Working Group on Drugs (Union Européenne)
Horizontal Working Group on Drugs (Europese Unie)

En 1999, le Biotechnology Working Party (BWP) a émis un “position paper” à propos des tests ALT pour les dons de sang ou de plasma humain (EMEA/CPMP/BWP/0385/99) (copie en annexe).
In 1999, heeft de Biotechnology Working Party (BWP) een “position paper” uitgebracht betreffende de ALT-tests voor menselijk bloed- of plasmadonatie (EMEA/CPMP/BWP/0385/99) (kopie in bijlage).

“Pfizer’s commitments build on our ongoing efforts to fight neglected tropical diseases, which includes the work done through our support of the International Trachoma Initiative, by our colleagues who participate in our Global Health Fellows program, and through our participation in WIPO Re: Search -- a publicprivate consortium for sharing intellectual property and expertise with the global health research community to promote the development of new drugs, vaccines and diagnostics for the treatment of neglected tropical diseases, malaria and tuberculosis.
“Pfizer’s commitments build on our ongoing efforts to fight neglected tropical diseases, which includes the work done through our support of the International Trachoma Initiative, by our colleagues who participate in our Global Health Fellows program, and through our participation in WIPO Re: Search -- a publicprivate consortium for sharing intellectual property and expertise with the global health research community to promote the development of new drugs, vaccines and diagnostics for the treatment of neglected tropical diseases, malaria and tuberculosis. “We are proud to be a part of this innovative effort to support a healthier world”.

“At Pfizer, we are working to combat NTDs by collaborating on drug development, broadening access to medicines and strengthening health care delivery for underserved people.
“This effort builds on the ongoing work of many partners committed to improving the lives of the 1 billion people affected by NTDs, most of whom are among the world’s poorest. “At Pfizer, we are working to combat NTDs by collaborating on drug development, broadening access to medicines and strengthening health care delivery for underserved people.